Director Group Portfolio Execution (all genders) part/full-time

优缺点分析

角色解读

• Progression to VP of Portfolio Execution or broader executive roles in Corporate Development/M&A.
• Opportunity to lead larger, more complex global transactions and shape the company's long-term strategic portfolio.
• Lead end-to-end M&A integration and carve-out projects for small to mid-size strategic deals.
• Act as the primary point of contact, aligning cross-functional teams and stakeholders to ensure smooth transition and value realization.
• Manage post-closing services, budgets, and organizational changes while reporting to the VP of Portfolio Execution.
• Extensive experience in management consulting and operational post-merger integration/carve-outs.
• Strong financial acumen, project management, and change management skills.
• Ability to navigate complex matrix organizations and build credibility with C-suite and external partners.

申请策略

• Emphasize your cultural and political savvy, as well as your ability to manage change and communicate effectively across different business units and countries.
• Highlight specific M&A integration and carve-out projects, emphasizing deal size, complexity, and your specific role.
• Showcase experience in matrix organizations and cross-functional leadership.
• Quantify synergy realization and successful post-closing transitions.
• Deepen knowledge in AI tools for project execution and synergy acceleration, as mentioned in preferred qualifications.
• Enhance financial modeling and valuation skills if not already strong.

面试指南

• Use the STAR method (Situation, Task, Action, Result) to structure your answers.
• Focus on the 'Action' part to highlight your leadership, decision-making, and stakeholder management skills.
• Always tie the 'Result' back to financial or strategic value creation.
• Can you walk me through a complex carve-out or integration project you led from due diligence to post-closing?
• How do you handle conflicts between different business units during the integration process?
• Describe a time when you had to pivot an implementation strategy due to unforeseen risks.
• How do you ensure synergy targets are met and tracked effectively?
• Research Merck's recent M&A activities, especially in Healthcare and Life Science sectors.